Last reviewed · How we verify
dexamethasone combined with ondansetron — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
dexamethasone combined with ondansetron (dexamethasone combined with ondansetron) — AIPING ZHOU.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| dexamethasone combined with ondansetron TARGET | dexamethasone combined with ondansetron | AIPING ZHOU | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- dexamethasone combined with ondansetron CI watch — RSS
- dexamethasone combined with ondansetron CI watch — Atom
- dexamethasone combined with ondansetron CI watch — JSON
- dexamethasone combined with ondansetron alone — RSS
Cite this brief
Drug Landscape (2026). dexamethasone combined with ondansetron — Competitive Intelligence Brief. https://druglandscape.com/ci/dexamethasone-combined-with-ondansetron. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab